Advertisement
Screener

Tilray Brands, Inc. (TLRY) Cost of Revenue

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Cost of Revenue

Tilray Brands, Inc. (TLRY) reported Cost of Revenue of $35.25 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.

Discontinued › Expense Statement

us-gaap:CostOfRevenue · last filed 2019-11-13

  • Tilray Brands, Inc. cost of revenue for the quarter ending 2019-09-30 was $35.25M, a 405.06% increase year-over-year.
  • Tilray Brands, Inc. cost of revenue for the quarter ending 2019-06-30 was $33.63M, a 504.11% increase year-over-year.
  • Tilray Brands, Inc. cost of revenue for the quarter ending 2019-03-31 was $17.65M, a 351.25% increase year-over-year.
  • Tilray Brands, Inc. cost of revenue for the quarter ending 2018-12-31 was $12.40M, a 473.94% increase year-over-year.
  • Tilray Brands, Inc. cost of revenue for fiscal 2018 was $28.86M, a 214.98% increase from fiscal 2017.
  • Tilray Brands, Inc. cost of revenue for fiscal 2017 was $9.16M, a 8.15% decline from fiscal 2016.
  • Tilray Brands, Inc. cost of revenue for fiscal 2016 was $9.97M.
Period endCost of Revenue 3 monthCost of Revenue 6 monthCost of Revenue 9 monthCost of Revenue 12 month
2019-09-30$35.25M
10-Q · filed 2019-11-13
$68.88M
derived: sum of 2 quarters · filed 2019-11-13
$86.53M
10-Q · filed 2019-11-13
$98.93M
derived: sum of 4 quarters · filed 2019-11-13
2019-06-30$33.63M
10-Q · filed 2019-08-13
$51.28M
10-Q · filed 2019-08-13
$63.68M
derived: sum of 3 quarters · filed 2019-08-13
$70.66M
derived: sum of 4 quarters · filed 2019-11-13
2019-03-31$17.65M
10-Q · filed 2019-05-15
$30.05M
derived: sum of 2 quarters · filed 2019-05-15
$37.03M
derived: sum of 3 quarters · filed 2019-11-13
$42.60M
derived: sum of 4 quarters · filed 2019-11-13
2018-12-31$12.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$19.38M
derived: sum of 2 quarters · filed 2019-11-13
$24.94M
derived: sum of 3 quarters · filed 2019-11-13
$28.86M
10-K · filed 2019-03-25
2018-09-30$6.98M
10-Q · filed 2019-11-13
$12.55M
derived: sum of 2 quarters · filed 2019-11-13
$16.46M
10-Q · filed 2019-11-13
$18.62M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$5.57M
10-Q · filed 2019-08-13
$9.48M
10-Q · filed 2019-08-13
$11.64M
derived: sum of 3 quarters · filed 2019-08-13
$14.08M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$3.91M
10-Q · filed 2019-05-15
$6.07M
derived: sum of 2 quarters · filed 2019-05-15
$8.51M
derived: sum of 3 quarters · filed 2019-05-15
$10.79M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$2.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$4.60M
derived: sum of 2 quarters · filed 2019-03-25
$6.88M
derived: sum of 3 quarters · filed 2019-03-25
$9.16M
10-K · filed 2019-03-25
2017-09-30$2.44M
10-Q · filed 2018-11-14
$4.72M
derived: sum of 2 quarters · filed 2018-11-14
$7.00M
10-Q · filed 2018-11-14
2017-06-30$2.28M
10-Q · filed 2018-08-29
$4.56M
10-Q · filed 2018-08-29
2016-12-31$9.97M
10-K · filed 2019-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87